Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Galectin Therapeutics Inc.

GALT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of GALT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GALT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
GALT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GALT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in GALT holdings by institutional investors

Quarterly net insider trading by GALT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for GALT

Quiver Logo

No former government officials on record as having lobbied for GALT

Revolving Door Dashboard

GALT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

GALT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
GALT Income Statement
GALT Balance Sheet
GALT Cash Flow
U.S. Patents

New GALT patent grants

  • Patent Title: Methods for treatment of arthritis Aug. 16, 2022
  • Patent Title: Composition of novel carbohydrate drug for treatment of human diseases Oct. 13, 2020
  • Patent Title: Galactose-pronged polysaccharides in a formulation for antifibrotic therapies Aug. 18, 2020
  • Patent Title: Composition of novel carbohydrate drug for treatment of human diseases Sep. 24, 2019
  • Patent Title: Method for enhancing specific immunotherapies in cancer treatment Sep. 03, 2019
  • Patent Title: Composition of novel carbohydrate drug for treatment of human diseases May. 22, 2018
  • Patent Title: Method for treatment of pulmonary fibrosis May. 15, 2018
  • Patent Title: Method for enhancing specific immunotherapies in cancer treatment Jan. 23, 2018
  • Patent Title: Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase Sep. 19, 2017
  • Patent Title: Composition of novel carbohydrate drug for treatment of human diseases May. 16, 2017
  • Patent Title: Method for treatment of pulmonary fibrosis May. 17, 2016
  • Patent Title: Galactose-pronged polysaccharides in a formulation for antifibrotic therapies Dec. 01, 2015
  • Patent Title: Composition of novel carbohydrate drug for treatment of human diseases Feb. 24, 2015
  • Patent Title: Compositions of novel carbohydrate drug for treatment of human diseases Oct. 28, 2014
  • Patent Title: Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders Sep. 09, 2014
  • Patent Title: Galactose-pronged polysaccharides in a formulation for antifibrotic therapies May. 13, 2014
  • Patent Title: Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease Feb. 25, 2014
  • Patent Title: Galactose-pronged polysaccharides in a formulation for antifibrotic therapies Feb. 05, 2013
  • Patent Title: Galactose—pronged polysaccharides in a formulation for antifibrotic therapies Aug. 07, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to GALT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
GALT News

Recent insights relating to GALT

CNBC Recommendations

Recent picks made for GALT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GALT

GALT Analyst Ratings

GALT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
GALT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $GALT stock a Buy, Sell, or Hold?

  • What is the price target for $GALT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GALT Top Shareholders
Shareholder
Shares Held
GALT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $GALT stock?

  • Who owns the most shares of $GALT stock?

  • What funds own $GALT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GALT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GALT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About GALT

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

  • Address Norcross, GA
  • Market Cap 408.4 million
  • Employees 9
  • Industrial Classification Pharmaceutical Preparations

Galectin Therapeutics Inc. (GALT) Historical Stock Prices

Galectin Therapeutics Inc. (GALT) closed at $4.05 on September 23, 2026. Over the past year its adjusted close ranged from $2.08 to $6.51. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month+4.38%
  • 3 months+3.32%
  • Year to date-2.64%
  • 1 year-15.80%
  • 3 years+131.43%
  • 5 years-2.41%
  • Max-49.69%
See every congressional and insider trade on the GALT price chart

Quiver Premium charts GALT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 4.12 4.15 4.00 4.05 4.05 174,131
Sep 22, 2026 4.05 4.24 4.05 4.14 4.14 258,068
Sep 21, 2026 3.91 4.02 3.85 3.96 3.96 258,377
Sep 18, 2026 3.71 3.92 3.68 3.89 3.89 1,065,896
Sep 17, 2026 3.73 3.79 3.69 3.71 3.71 171,131
Sep 16, 2026 3.71 3.80 3.61 3.68 3.68 276,068
Sep 15, 2026 3.82 3.83 3.58 3.73 3.73 327,232
Sep 14, 2026 3.95 4.09 3.82 3.84 3.84 338,529
Sep 11, 2026 3.92 4.01 3.84 3.91 3.91 243,766
Sep 10, 2026 4.00 4.05 3.84 3.90 3.90 253,046
Sep 9, 2026 4.13 4.34 4.04 4.05 4.05 515,690
Sep 8, 2026 4.60 4.65 4.10 4.14 4.14 393,417
Sep 4, 2026 4.33 4.72 4.33 4.61 4.61 473,554
Sep 3, 2026 4.50 4.60 4.22 4.35 4.35 244,150
Sep 2, 2026 4.19 4.53 4.19 4.48 4.48 460,695
Sep 1, 2026 3.91 4.38 3.91 4.17 4.17 479,583
Aug 31, 2026 4.02 4.05 3.91 3.95 3.95 229,714
Aug 28, 2026 4.14 4.20 3.95 4.02 4.02 271,187
Aug 27, 2026 4.15 4.45 4.04 4.14 4.14 345,234
Aug 26, 2026 3.95 4.21 3.92 4.15 4.15 291,106
Aug 25, 2026 4.07 4.19 3.85 3.99 3.99 194,722
Aug 24, 2026 3.68 3.97 3.58 3.88 3.88 227,962
Aug 21, 2026 3.62 3.74 3.59 3.68 3.68 174,932
Aug 20, 2026 3.67 3.75 3.44 3.57 3.57 313,109
Aug 19, 2026 3.54 3.77 3.54 3.67 3.67 353,794
Aug 18, 2026 3.47 3.55 3.33 3.52 3.52 317,939
Aug 17, 2026 3.36 3.67 3.31 3.51 3.51 300,046
Aug 14, 2026 3.50 3.55 3.20 3.44 3.44 388,207
Aug 13, 2026 3.16 3.56 3.16 3.53 3.53 585,303
Aug 12, 2026 3.12 3.26 3.12 3.14 3.14 231,491
Aug 11, 2026 3.13 3.15 3.02 3.13 3.13 296,151
Aug 10, 2026 3.39 3.40 3.09 3.12 3.12 371,112
Aug 7, 2026 3.56 3.56 3.22 3.45 3.45 329,874
Aug 6, 2026 3.13 3.25 3.07 3.22 3.22 511,184
Aug 5, 2026 3.00 3.14 2.96 3.09 3.09 355,019
Aug 4, 2026 2.96 3.12 2.72 2.98 2.98 844,237
Aug 3, 2026 2.97 3.17 2.90 3.03 3.03 296,958
Jul 31, 2026 3.26 3.33 2.96 2.97 2.97 387,699
Jul 30, 2026 3.51 3.60 3.21 3.23 3.23 404,349
Jul 29, 2026 3.43 3.60 3.41 3.49 3.49 330,651
Jul 28, 2026 3.38 3.46 3.22 3.39 3.39 259,877
Jul 27, 2026 3.50 3.58 3.32 3.38 3.38 305,155
Jul 24, 2026 3.48 3.60 3.33 3.47 3.47 313,368
Jul 23, 2026 3.50 3.56 3.38 3.45 3.45 335,756
Jul 22, 2026 3.84 3.87 3.50 3.50 3.50 494,251
Jul 21, 2026 4.01 4.15 3.83 3.85 3.85 310,771
Jul 20, 2026 4.19 4.46 3.92 4.00 4.00 339,107
Jul 17, 2026 4.21 4.42 4.14 4.17 4.17 413,756
Jul 16, 2026 4.68 4.71 4.15 4.22 4.22 556,462
Jul 15, 2026 5.33 5.39 4.74 4.76 4.76 529,032
Jul 14, 2026 4.70 5.55 4.66 5.34 5.34 2,124,225
Jul 13, 2026 4.06 4.82 4.01 4.60 4.60 1,372,363
Jul 10, 2026 4.42 4.42 4.01 4.06 4.06 528,753
Jul 9, 2026 4.50 4.96 4.30 4.37 4.37 430,353
Jul 8, 2026 4.51 4.67 4.44 4.51 4.51 318,752
Jul 7, 2026 4.60 4.66 4.31 4.61 4.61 437,225
Jul 6, 2026 4.62 4.79 4.46 4.63 4.63 518,894
Jul 2, 2026 4.38 4.78 4.36 4.51 4.51 723,134
Jul 1, 2026 4.57 4.64 4.28 4.33 4.33 647,423
Jun 30, 2026 4.85 4.97 4.19 4.64 4.64 1,123,925
Jun 29, 2026 5.03 5.19 4.75 4.97 4.97 1,853,080
Jun 26, 2026 4.18 5.03 4.18 4.99 4.99 6,475,738
Jun 25, 2026 3.96 4.37 3.88 4.23 4.23 1,856,659
Jun 24, 2026 3.15 3.99 3.09 3.92 3.92 2,052,252
Jun 23, 2026 2.71 3.70 2.71 3.12 3.12 3,906,157
Jun 22, 2026 2.82 2.99 2.77 2.80 2.80 260,759
Jun 18, 2026 2.79 2.93 2.77 2.83 2.83 336,750
Jun 17, 2026 2.65 2.88 2.60 2.77 2.77 266,230
Jun 16, 2026 2.62 2.71 2.50 2.64 2.64 383,014
Jun 15, 2026 2.67 2.78 2.58 2.62 2.62 291,702
Jun 12, 2026 2.61 2.76 2.58 2.67 2.67 282,155
Jun 11, 2026 2.42 2.64 2.35 2.61 2.61 304,645
Jun 10, 2026 2.34 2.50 2.32 2.38 2.38 263,365
Jun 9, 2026 2.42 2.54 2.38 2.41 2.41 294,959
Jun 8, 2026 2.35 2.43 2.34 2.40 2.40 193,300
Jun 5, 2026 2.35 2.40 2.25 2.33 2.33 215,793
Jun 4, 2026 2.35 2.45 2.35 2.38 2.38 111,432
Jun 3, 2026 2.43 2.43 2.30 2.35 2.35 226,101
Jun 2, 2026 2.60 2.63 2.40 2.42 2.42 280,231
Jun 1, 2026 2.56 2.70 2.50 2.61 2.61 315,584
May 29, 2026 2.60 2.60 2.43 2.52 2.52 282,381
May 28, 2026 2.78 2.87 2.56 2.57 2.57 354,178
May 27, 2026 2.82 2.85 2.67 2.70 2.70 430,647
May 26, 2026 2.57 3.11 2.52 2.79 2.79 987,612
May 22, 2026 2.52 2.63 2.49 2.50 2.50 302,890
May 21, 2026 2.20 2.56 2.15 2.52 2.52 391,523
May 20, 2026 2.11 2.22 2.08 2.21 2.21 174,665
May 19, 2026 2.18 2.18 2.07 2.08 2.08 312,188
May 18, 2026 2.22 2.32 2.12 2.19 2.19 290,775
May 15, 2026 2.36 2.38 2.17 2.17 2.17 366,292
May 14, 2026 2.27 2.40 2.24 2.35 2.35 239,285
May 13, 2026 2.25 2.33 2.22 2.23 2.23 411,067
May 12, 2026 2.21 2.27 2.17 2.25 2.25 279,262
May 11, 2026 2.09 2.40 2.08 2.21 2.21 654,298
May 8, 2026 2.13 2.13 2.07 2.10 2.10 207,489
May 7, 2026 2.21 2.24 2.02 2.11 2.11 501,148
May 6, 2026 2.26 2.30 2.18 2.25 2.25 382,994
May 5, 2026 2.31 2.38 2.19 2.23 2.23 320,108
May 4, 2026 2.26 2.35 2.24 2.29 2.29 282,802
May 1, 2026 2.29 2.30 2.21 2.27 2.27 178,590
Apr 30, 2026 2.28 2.35 2.23 2.27 2.27 301,564
Apr 29, 2026 2.31 2.32 2.23 2.25 2.25 265,011
Apr 28, 2026 2.34 2.39 2.31 2.32 2.32 137,956
Apr 27, 2026 2.33 2.49 2.31 2.37 2.37 180,215
Apr 24, 2026 2.36 2.39 2.31 2.33 2.33 180,518
Apr 23, 2026 2.43 2.50 2.36 2.37 2.37 168,212
Apr 22, 2026 2.29 2.45 2.28 2.45 2.45 290,411
Apr 21, 2026 2.32 2.37 2.24 2.28 2.28 312,316
Apr 20, 2026 2.46 2.46 2.25 2.29 2.29 402,555
Apr 17, 2026 2.31 2.49 2.29 2.45 2.45 540,474
Apr 16, 2026 2.58 2.60 2.23 2.26 2.26 538,140
Apr 15, 2026 2.49 2.57 2.48 2.56 2.56 309,406
Apr 14, 2026 2.36 2.48 2.36 2.47 2.47 121,151
Apr 13, 2026 2.29 2.45 2.26 2.35 2.35 219,479
Apr 10, 2026 2.43 2.45 2.25 2.30 2.30 201,612
Apr 9, 2026 2.21 2.45 2.21 2.43 2.43 402,829
Apr 8, 2026 2.24 2.39 2.20 2.22 2.22 517,457
Apr 7, 2026 2.55 2.55 2.18 2.19 2.19 738,480
Apr 6, 2026 2.70 2.77 2.50 2.56 2.56 534,276
Apr 2, 2026 2.66 2.72 2.55 2.67 2.67 242,842
Apr 1, 2026 2.78 2.92 2.61 2.68 2.68 739,421
Mar 31, 2026 2.55 2.80 2.55 2.79 2.79 214,938
Mar 30, 2026 2.70 2.70 2.56 2.57 2.57 189,891
Mar 27, 2026 2.80 2.85 2.65 2.68 2.68 331,496
Mar 26, 2026 2.93 3.00 2.80 2.80 2.80 186,589
Mar 25, 2026 2.92 3.02 2.86 2.93 2.93 168,782
Mar 24, 2026 2.85 2.86 2.77 2.83 2.83 141,823
Mar 23, 2026 2.79 2.88 2.75 2.86 2.86 150,850
Mar 20, 2026 2.80 2.87 2.73 2.75 2.75 147,639
Mar 19, 2026 2.80 2.83 2.63 2.80 2.80 354,484
Mar 18, 2026 3.14 3.18 2.80 2.81 2.81 399,540
Mar 17, 2026 3.15 3.31 3.11 3.15 3.15 268,541
Mar 16, 2026 3.12 3.28 3.06 3.18 3.18 251,099
Mar 13, 2026 3.15 3.28 3.05 3.09 3.09 277,426
Mar 12, 2026 3.00 3.34 2.94 3.16 3.16 800,480
Mar 11, 2026 3.06 3.11 2.96 3.01 3.01 482,106
Mar 10, 2026 3.38 3.50 3.00 3.06 3.06 686,141
Mar 9, 2026 3.09 3.47 3.09 3.35 3.35 737,778
Mar 6, 2026 3.02 3.15 3.00 3.10 3.10 350,607
Mar 5, 2026 3.11 3.21 3.00 3.03 3.03 341,655
Mar 4, 2026 3.01 3.21 2.95 3.11 3.11 401,287
Mar 3, 2026 3.03 3.06 2.86 2.98 2.98 375,795
Mar 2, 2026 2.98 3.10 2.87 3.06 3.06 378,333
Feb 27, 2026 3.11 3.17 2.93 2.98 2.98 530,493
Feb 26, 2026 3.22 3.22 2.98 3.14 3.14 301,491
Feb 25, 2026 3.18 3.32 3.16 3.22 3.22 152,197
Feb 24, 2026 3.04 3.18 2.99 3.16 3.16 215,540
Feb 23, 2026 2.97 3.08 2.91 3.03 3.03 107,847
Feb 20, 2026 2.92 3.10 2.90 2.97 2.97 156,726
Feb 19, 2026 2.83 3.00 2.81 2.93 2.93 159,691
Feb 18, 2026 2.73 2.92 2.71 2.82 2.82 127,059
Feb 17, 2026 2.74 2.81 2.69 2.74 2.74 133,831
Feb 13, 2026 2.72 2.81 2.70 2.76 2.76 158,309
Feb 12, 2026 2.75 2.83 2.62 2.81 2.81 154,973
Feb 11, 2026 2.76 2.84 2.65 2.76 2.76 253,765
Feb 10, 2026 2.73 2.88 2.68 2.76 2.76 328,506
Feb 9, 2026 2.78 2.83 2.61 2.72 2.72 407,382
Feb 6, 2026 2.82 2.89 2.67 2.80 2.80 473,803
Feb 5, 2026 2.97 2.98 2.82 2.83 2.83 221,573
Feb 4, 2026 3.23 3.23 2.90 2.96 2.96 236,166
Feb 3, 2026 3.00 3.30 3.00 3.25 3.25 301,697
Feb 2, 2026 2.84 3.04 2.77 3.00 3.00 269,703
Jan 30, 2026 2.92 2.95 2.76 2.83 2.83 266,104
Jan 29, 2026 3.07 3.09 2.90 2.93 2.93 387,253
Jan 28, 2026 3.15 3.23 3.06 3.08 3.08 127,937
Jan 27, 2026 3.12 3.24 3.08 3.15 3.15 198,479
Jan 26, 2026 3.27 3.28 3.10 3.12 3.12 310,079
Jan 23, 2026 3.53 3.53 3.28 3.31 3.31 283,892
Jan 22, 2026 3.17 3.56 3.14 3.53 3.53 286,643
Jan 21, 2026 3.00 3.18 2.93 3.17 3.17 448,465
Jan 20, 2026 3.02 3.04 2.94 2.99 2.99 382,200
Jan 16, 2026 3.08 3.14 2.96 3.04 3.04 514,911
Jan 15, 2026 3.04 3.27 2.96 3.15 3.15 329,669
Jan 14, 2026 3.11 3.11 2.90 3.00 3.00 387,853
Jan 13, 2026 3.20 3.20 3.00 3.07 3.07 373,820
Jan 12, 2026 3.13 3.18 3.02 3.16 3.16 237,203
Jan 9, 2026 3.16 3.19 2.94 3.15 3.15 671,933
Jan 8, 2026 3.52 3.55 3.18 3.20 3.20 657,826
Jan 7, 2026 3.47 3.67 3.45 3.54 3.54 456,954
Jan 6, 2026 3.86 3.95 3.34 3.45 3.45 905,530
Jan 5, 2026 4.06 4.17 3.80 3.88 3.88 604,202
Jan 2, 2026 4.20 4.35 3.97 4.05 4.05 542,703
Dec 31, 2025 4.09 4.20 4.01 4.16 4.16 325,582
Dec 30, 2025 4.05 4.14 3.97 4.08 4.08 426,723
Dec 29, 2025 4.01 4.13 3.97 4.08 4.08 283,851
Dec 26, 2025 4.05 4.19 3.90 4.05 4.05 413,775
Dec 24, 2025 3.97 4.06 3.90 4.03 4.03 247,449
Dec 23, 2025 4.00 4.13 3.53 3.99 3.99 1,052,400
Dec 22, 2025 4.31 4.42 3.96 4.03 4.03 958,281
Dec 19, 2025 4.64 4.83 3.80 4.38 4.38 4,121,482
Dec 18, 2025 6.55 6.95 6.12 6.16 6.16 526,875
Dec 17, 2025 6.57 7.13 6.46 6.47 6.47 1,038,591
Dec 16, 2025 6.57 6.78 6.03 6.20 6.20 526,378
Dec 15, 2025 6.24 6.67 6.10 6.51 6.51 520,045
Dec 12, 2025 5.72 6.40 5.54 6.25 6.25 760,704
Dec 11, 2025 5.49 5.95 5.12 5.71 5.71 706,353
Dec 10, 2025 6.00 6.13 5.10 5.49 5.49 1,165,012
Dec 9, 2025 6.00 6.32 5.91 5.94 5.94 527,711
Dec 8, 2025 5.69 6.09 5.69 6.02 6.02 580,879
Dec 5, 2025 6.28 6.66 5.67 5.74 5.74 774,143
Dec 4, 2025 5.77 6.52 5.72 6.30 6.30 743,860
Dec 3, 2025 5.44 5.95 5.43 5.70 5.70 599,300
Dec 2, 2025 5.50 5.62 5.31 5.46 5.46 302,264
Dec 1, 2025 5.76 5.77 5.50 5.51 5.51 238,002
Nov 28, 2025 5.79 5.85 5.60 5.73 5.73 101,423
Nov 26, 2025 5.74 5.85 5.66 5.76 5.76 187,568
Nov 25, 2025 5.50 5.88 5.50 5.71 5.71 260,239
Nov 24, 2025 5.35 5.63 5.33 5.51 5.51 211,719
Nov 21, 2025 5.67 6.03 5.23 5.35 5.35 408,849
Nov 20, 2025 5.75 6.16 5.70 5.74 5.74 275,409
Nov 19, 2025 6.14 6.29 5.72 5.74 5.74 263,143
Nov 18, 2025 5.91 6.32 5.59 6.19 6.19 500,238
Nov 17, 2025 5.61 6.10 5.61 6.00 6.00 470,902
Nov 14, 2025 5.10 5.69 5.10 5.51 5.51 238,896
Nov 13, 2025 5.87 5.90 5.20 5.53 5.53 482,245
Nov 12, 2025 5.55 5.90 5.55 5.83 5.83 297,297
Nov 11, 2025 5.36 5.53 5.15 5.50 5.50 311,514
Nov 10, 2025 5.40 6.15 5.20 5.20 5.20 856,484
Nov 7, 2025 5.60 5.71 5.05 5.20 5.20 500,799
Nov 6, 2025 5.56 5.87 5.51 5.58 5.58 245,201
Nov 5, 2025 5.70 6.00 5.58 5.63 5.63 299,048
Nov 4, 2025 6.00 6.25 5.55 5.67 5.67 575,588
Nov 3, 2025 5.65 6.02 5.60 6.00 6.00 585,145
Oct 31, 2025 5.14 5.81 5.14 5.81 5.81 461,079
Oct 30, 2025 5.20 5.29 5.05 5.07 5.07 101,264
Oct 29, 2025 5.20 5.25 5.03 5.11 5.11 454,504
Oct 28, 2025 5.05 5.26 5.05 5.14 5.14 1,435,032
Oct 27, 2025 5.23 5.34 5.09 5.10 5.10 184,982
Oct 24, 2025 5.17 5.37 5.17 5.23 5.23 195,000
Oct 23, 2025 4.97 5.16 4.89 5.13 5.13 121,289
Oct 22, 2025 5.30 5.30 4.77 4.88 4.88 345,331
Oct 21, 2025 5.20 5.35 5.11 5.30 5.30 229,833
Oct 20, 2025 5.06 5.26 5.02 5.09 5.09 235,499
Oct 17, 2025 5.05 5.12 4.89 4.99 4.99 177,900
Oct 16, 2025 5.14 5.24 4.96 5.05 5.05 257,960
Oct 15, 2025 5.05 5.25 5.01 5.19 5.19 220,935
Oct 14, 2025 5.13 5.14 4.87 4.96 4.96 344,415
Oct 13, 2025 4.82 5.35 4.73 5.10 5.10 518,936
Oct 10, 2025 4.77 4.78 4.56 4.72 4.72 225,337
Oct 9, 2025 4.70 4.85 4.69 4.75 4.75 182,464
Oct 8, 2025 4.80 4.84 4.66 4.74 4.74 256,878
Oct 7, 2025 4.58 4.82 4.47 4.77 4.77 441,097
Oct 6, 2025 4.39 4.72 4.38 4.44 4.44 246,958
Oct 3, 2025 4.35 4.45 4.21 4.33 4.33 213,317
Oct 2, 2025 4.20 4.45 4.16 4.25 4.25 227,183
Oct 1, 2025 4.24 4.34 4.14 4.18 4.18 206,659
Sep 30, 2025 4.12 4.43 4.08 4.24 4.24 270,715
Sep 29, 2025 4.60 4.62 4.19 4.22 4.22 277,049
Sep 26, 2025 4.56 4.79 4.50 4.55 4.55 154,909
Sep 25, 2025 4.74 4.88 4.45 4.61 4.61 216,874
Sep 24, 2025 5.06 5.06 4.70 4.75 4.75 166,294
Sep 23, 2025 4.93 5.01 4.80 4.81 4.81 149,175

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Galectin Therapeutics Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at GALT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation